Suntrust Banks Inc. lessened its stake in shares of Icon Plc (NASDAQ:ICLR) by 3.1% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 43,276 shares of the medical research company’s stock after selling 1,377 shares during the quarter. Suntrust Banks Inc. owned approximately 0.08% of Icon Plc worth $4,230,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. Shine Investment Advisory Services Inc. purchased a new stake in shares of Icon Plc during the second quarter valued at approximately $103,000. Acrospire Investment Management LLC boosted its stake in shares of Icon Plc by 20.1% during the second quarter. Acrospire Investment Management LLC now owns 1,195 shares of the medical research company’s stock valued at $117,000 after purchasing an additional 200 shares during the period. Parallel Advisors LLC boosted its stake in shares of Icon Plc by 20.7% during the second quarter. Parallel Advisors LLC now owns 1,265 shares of the medical research company’s stock valued at $133,000 after purchasing an additional 217 shares during the period. Huntington National Bank boosted its stake in shares of Icon Plc by 5.0% during the second quarter. Huntington National Bank now owns 1,630 shares of the medical research company’s stock valued at $159,000 after purchasing an additional 77 shares during the period. Finally, US Bancorp DE boosted its stake in shares of Icon Plc by 15.0% during the first quarter. US Bancorp DE now owns 1,929 shares of the medical research company’s stock valued at $154,000 after purchasing an additional 251 shares during the period. 90.61% of the stock is owned by hedge funds and other institutional investors.

Shares of Icon Plc (NASDAQ ICLR) opened at 110.97 on Monday. The stock has a market cap of $6.00 billion, a price-to-earnings ratio of 22.51 and a beta of 0.61. The company has a 50-day moving average price of $108.70 and a 200-day moving average price of $93.99. Icon Plc has a 52 week low of $73.76 and a 52 week high of $117.53.

Icon Plc (NASDAQ:ICLR) last posted its quarterly earnings data on Thursday, July 27th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.30 by $0.01. Icon Plc had a return on equity of 28.72% and a net margin of 15.97%. The company had revenue of $431.00 million during the quarter, compared to analysts’ expectations of $430.68 million. During the same quarter in the previous year, the business earned $1.14 EPS. Icon Plc’s revenue was up 5.0% compared to the same quarter last year. Equities analysts anticipate that Icon Plc will post $5.32 EPS for the current year.

ICLR has been the subject of a number of analyst reports. ValuEngine lowered Icon Plc from a “buy” rating to a “hold” rating in a research note on Wednesday, May 31st. Credit Suisse Group reaffirmed an “outperform” rating and issued a $102.00 price target (up previously from $91.00) on shares of Icon Plc in a research note on Tuesday, June 6th. Robert W. Baird dropped their price target on Icon Plc from $107.00 to $97.00 and set an “outperform” rating for the company in a research note on Friday, June 9th. BidaskClub lowered Icon Plc from a “strong-buy” rating to a “buy” rating in a research note on Friday, June 16th. Finally, Zacks Investment Research raised Icon Plc from a “hold” rating to a “buy” rating and set a $108.00 price target for the company in a research note on Tuesday, June 27th. Three equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have issued a strong buy rating to the company. The company currently has a consensus rating of “Buy” and an average price target of $113.00.

TRADEMARK VIOLATION WARNING: “Suntrust Banks Inc. Has $4.23 Million Stake in Icon Plc (ICLR)” was first reported by Daily Political and is the sole property of of Daily Political. If you are viewing this piece on another domain, it was copied illegally and reposted in violation of international copyright & trademark laws. The legal version of this piece can be accessed at https://www.dailypolitical.com/2017/09/25/suntrust-banks-inc-has-4-23-million-stake-in-icon-plc-iclr.html.

Icon Plc Company Profile

ICON public limited company is a contract research organization (CRO), which is engaged in providing outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company is engaged in the strategic development, management and analysis of programs that support the various stages of the clinical development process, from compound selection to Phase I-IV clinical studies.

Institutional Ownership by Quarter for Icon Plc (NASDAQ:ICLR)

Receive News & Ratings for Icon Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Icon Plc and related companies with MarketBeat.com's FREE daily email newsletter.